0001367644-20-000012.txt : 20200225 0001367644-20-000012.hdr.sgml : 20200225 20200225162831 ACCESSION NUMBER: 0001367644-20-000012 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200221 FILED AS OF DATE: 20200225 DATE AS OF CHANGE: 20200225 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hauer Jerome M CENTRAL INDEX KEY: 0001294935 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33137 FILM NUMBER: 20651060 MAIL ADDRESS: STREET 1: 4435 EASTGATE MALL STREET 2: SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Emergent BioSolutions Inc. CENTRAL INDEX KEY: 0001367644 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 141902018 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 BUSINESS PHONE: 240-631-3200 MAIL ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 4 1 wf-form4_158266609423712.xml FORM 4 X0306 4 2020-02-21 0 0001367644 Emergent BioSolutions Inc. EBS 0001294935 Hauer Jerome M 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 1 0 0 0 Common Stock 2020-02-21 4 S 0 6572 70 D 11752 D Consists of restricted stock units granted under the Company's stock incentive plan, as amended and restated. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Hauer. /s/ S. Scott Lieberman, Attorney-in-fact 2020-02-25